NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

TB & Outbreaks Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB & Outbreaks Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Life Sciences



Researchers at MS Center target life sciences



October 14th, 2008

According to a study from Belo Horizonte, Brazil, "The leishmanicidal activity of four batches of meglumine antimoniate, produced in Farmanguinhos-Fiocruz, Brazil (TAMs), was assessed and compared to Glucantime (R)-Aventis Pharma Ltda. Using the amastigote-like in vitro model, the active concentrations of Sbv varied from 10 mu g/ml to 300 mu g/ml for L. ( L.) chagasi and from 50 mu g/ml to 300 mu g/ml for L. ( L.) amazonensis, with no statistically significant differences among the four batches of TAMs and Glucantime (R)."

"The inhibitory concentrations (IC50) determined by the amastigote-infected macrophage model for TAM01/03 and Glucantime (R) were, respectively: 26.3...


Source: TB & Outbreaks Week (2008-10-14)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login